For Dirk Müller, Dr-Ing, manager media and process development at Sartorius, cost reduction is the underlying motivation for scale-down modeling and process intensification. “Biopharma firms are ...

The lack of common standards and problems with reproducing and verifying existing datasets are widespread in the biotech community. However, a new tool named Memote paves the way for quality testing ...

GEN: Can you speak to your experiences with scale-down screening model systems? Do you have a preference? Sieck: The best screening model depends on specific needs. An ideal small-scale model should ...